A small group of scientists run tests in a state of the art laboratory; they are all wearing surgical gloves and lab coats.

AbbVie’s update on COVID-19 and the coronavirus crisis

No expected impact on drug supply

We continue to closely monitor manufacturing and supply chain resources around the world and do not anticipate any disruption to our medicine supply as a result of COVID-19.

Patients taking AbbVie medications

We understand your need to know more about the coronavirus. If you are on an AbbVie treatment, please speak with your doctor regarding any questions you may have. Your doctor can provide medical advice to address your individual needs.

Healthcare providers

If you are a registered healthcare provider with questions about COVID-19 and AbbVie medications, please visit AbbVie's medical information website.

Visit: www.abbviemedinfo.com

Partnering with Global Health Authorities

We are committed to making a meaningful contribution to efforts to combat this global public health crisis and are collaborating with global health authorities and institutions, including the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), to respond to the needs of patients impacted by COVID-19. Specifically, we have taken action through the provision of one of our Medicinal Products as an experimental option for treatment of COVID-19. We’ve also joined the Innovative Medicines Initiative to support research and discovery of targeted medicines against COVID-19.


AbbVie Medical Information

World Health Organization Coronavirus disease (COVID-19) webpage
WHO website